Exponent, Inc. $EXPO reported a strong second quarter for 2026, with revenue rising 20.9% year over year to $171.6 million. The company also delivered higher profitability, as operating profit climbed 63.1% to $28.0 million and net income attributable to common shareholders increased 10.7% to $29.4 million.
Results topped expectations, with revenue above the $150.5 million estimate and diluted earnings per share of $0.60 also ahead of the $0.56 forecast. Gross profit matched revenue at $171.6 million, while diluted EPS improved 15.4% from a year earlier.
- Revenue: $171.6 million, up 20.9% year over year
- Operating profit: $28.0 million, up 63.1% year over year
- Net income: $29.4 million, up 10.7% year over year
- Diluted EPS: $0.60, above estimates
On the balance sheet, cash and cash equivalents stood at $66.6 million, while total liabilities rose to $364.1 million. Operating cash flow was negative $1.0 million in the quarter, and capital spending totaled $2.5 million.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Exponent, Inc. Insider Trading Activity
Exponent, Inc. insiders have traded $EXPO stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $EXPO stock by insiders over the last 6 months:
- CATHERINE CORRIGAN (Chief Executive Officer) has made 0 purchases and 11 sales selling 21,791 shares for an estimated $1,362,952.
- JOHN PYE (VP Global Offices & Innovation) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $303,897.
- JOSEPH RAKOW (Group Vice President) sold 2,945 shares for an estimated $160,973
- JOSEPH SALA (Group Vice President) sold 2,066 shares for an estimated $117,059
- BRADLEY A JAMES (Group Vice President) sold 2,000 shares for an estimated $114,930
- RICHARD REISS (Group Vice President) sold 1,672 shares for an estimated $98,062
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Exponent, Inc. Hedge Fund Activity
We have seen 165 institutional investors add shares of Exponent, Inc. stock to their portfolio, and 170 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEUBERGER BERMAN GROUP LLC removed 754,460 shares (-51.0%) from their portfolio in Q1 2026, for an estimated $49,228,515
- CONESTOGA CAPITAL ADVISORS, LLC removed 640,801 shares (-33.6%) from their portfolio in Q2 2026, for an estimated $37,653,466
- TWO SIGMA INVESTMENTS, LP added 577,602 shares (+110.3%) to their portfolio in Q1 2026, for an estimated $37,688,530
- POINT72 ASSET MANAGEMENT, L.P. removed 520,453 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $33,959,558
- AQR CAPITAL MANAGEMENT LLC added 433,537 shares (+79.2%) to their portfolio in Q1 2026, for an estimated $28,288,289
- DEUTSCHE BANK AG\ added 322,828 shares (+748.0%) to their portfolio in Q1 2026, for an estimated $21,064,527
- GOLDMAN SACHS GROUP INC added 301,622 shares (+63.2%) to their portfolio in Q1 2026, for an estimated $19,680,835
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Exponent, Inc. Government Contracts
We have seen $2,304,546 of award payments to $EXPO over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROCURE LIQUEFIED NATURAL GAS (LNG) TECHNICAL EXPERTISE SERVICES TO REVIEW ABNORMAL OPERATING CONDITIONS OR...: $603,750
- FARE-NET: $505,740
- CARD ANALYSIS & QUALITY ASSURANCE: $223,751
- EXPERT WITNESS/FY26ECU027: $147,535
- EXPERT WITNESS SERVICES: $101,850
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
Exponent, Inc. Price Targets
Multiple analysts have issued price targets for $EXPO recently. We have seen 2 analysts offer price targets for $EXPO in the last 6 months, with a median target of $77.5.
Here are some recent targets:
- Tomohiko Sano from JP Morgan set a target price of $80.0 on 05/15/2026
- Joshua Chan from UBS set a target price of $75.0 on 05/01/2026
